Biotech Essentials

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 24.08.2021.

#stocks
#biotech
#breastcancer
#dermatology
#Cancers
#AI
#ArtificiallIntelligence
#cancer
#HealthTech

Healthcare

@SWLifeSciences shared
On Aug 19, 2021
Biotech Offering Significant Return Potential Advances Lead Breast Cancer Trials: https://t.co/RD0I2MkZSv An H.C. Wainwright report noted Oncolytics' overall pelareorep program is on track with near-term catalysts expected. $ONCY #biotech #stocks @Oncolytics #breastcancer https://t.co/LPAw114nD5
Open
Biotech Offering Significant Return Potential Advances Lead Breast Cancer Trials

Biotech Offering Significant Return Potential Advances Lead Breast Cancer Trials

An H.C. Wainwright & Co. report noted Oncolytics Biotech's overall pelareorep program is on track with several near-term catalysts expected.

@matthewherper shared
On Aug 19, 2021
‘Remember her as the badass she was.’ Great @pharmalot column. https://t.co/VxqJClLd6p via @statnews
Open
‘Remember her as the badass she was’: ALS patient who died should force Biogen, others to anticipate expanded access issues

‘Remember her as the badass she was’: ALS patient who died should force Biogen, others to anticipate expanded access issues

During her final months, Lisa Stockman Mauriello battled Biogen for access to an experimental drug for ALS, a fatal neurological disease.

@Biotechnology shared
On Aug 20, 2021
BioSpace Movers & Shakers, Aug. 20 https://t.co/eQiy1NTz5P https://t.co/GlGfNRIDi9
Open
BioSpace Movers & Shakers, Aug. 20

BioSpace Movers & Shakers, Aug. 20

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

@SWLifeSciences shared
On Aug 18, 2021
Platform Therapeutics Co. Posts Positive Revenue Surprise in Q2 on Higher Dermatology Product Sales: https://t.co/usN3cfGkrY Dawson James stated that Fortress Biotech's #dermatology business shows good growth potential. $FBIO $MBIO $CKPT #biotech #stocks @fortressbio https://t.co/RzPxvbwTh6
Open
Platform Therapeutics Co. Posts Positive Revenue Surprise in Q2 on Higher Dermatology Product Sales

Platform Therapeutics Co. Posts Positive Revenue Surprise in Q2 on Higher Dermatology Product Sales

Dawson James Securities Inc. stated in a research update that Fortress Biotech Inc.'s dermatology business shows good growth potential and helped drive a positive revenue surprise in Q2/21. ...

@Biotechnology shared
On Aug 18, 2021
Money on the Move: August 11 – 17 https://t.co/tQsarb0YmU https://t.co/Erco8cjkCl
Open
Money on the Move: August 11 – 17

Money on the Move: August 11 – 17

Here’s the shortlist of which life sciences companies took a dip in the money pool this week.

@HealthcareLdr shared
On Aug 21, 2021
#AI Blood Test Can Spot Lung 🫁#Cancers With 90% Accuracy https://t.co/hRsedlIdbu @futurism #HealthTech #cancer #ArtificiallIntelligence https://t.co/hn1PiuNwa6
Open
AI Blood Test Can Spot Lung Cancers With 90 Percent Accuracy

AI Blood Test Can Spot Lung Cancers With 90 Percent Accuracy

A commercial lung screening test could be coming soon.

@matthewherper shared
On Aug 21, 2021
Biotech founder David Sabatini placed on leave after harassment probe. https://t.co/Z9oIEn9eyf
Open
Biotech founder David Sabatini placed on leave following investigation into sexual harassment

Biotech founder David Sabatini placed on leave following investigation into sexual harassment

The prominent biology professor and biotech founder at MIT has been accused of sexual harassment and placed on administrative leave.

@BIODeutschland shared
On Aug 19, 2021
Thomas Christély joins management of MetrioPharm AG as CEO https://t.co/J2taUjbIfa
Open
Thomas Christély joins management of MetrioPharm AG as CEO

Thomas Christély joins management of MetrioPharm AG as CEO

Zurich, August 19, 2021. Press Release: Thomas Christély to start as CEO of MetrioPharm AG on October 1, 2021. Dr. Wolfgang Brysch will accelerate expansion of clinical development as CSO & ...